Stephen Mayo's Net Worth
$1.44 Million
Who is Stephen Mayo?
Stephen Mayo has an estimated net worth of $1.44 Million. This is based on reported shares across multiple companies, which include Merck & Co., Inc., Sarepta Therapeutics, Inc., and Allogene Therapeutics, Inc..
SEC CIK
Stephen Mayo's CIK is 0001849061
Past Insider Trading and Trends
2022 was Stephen Mayo's most active year for acquiring shares with 5 total transactions. Stephen Mayo's most active month to acquire stocks was the month of February. 2022 was Stephen Mayo's most active year for disposing of shares, totalling 1 transactions. Stephen Mayo's most active month to dispose stocks was the month of February. 2024 saw Stephen Mayo paying a total of $220,000.00 for 198,359.43 shares, this is the most they've acquired in one year. In 2024 Stephen Mayo cashed out on 3,135 shares for a total of $385,479.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Merck & Co., Inc. (MRK) Snapshot price: $117.36
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $128.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.13% | -3.13K |
$122.96 | -$385,479.60 | 6.62K |
Mar 5
| |||
Form 4
| +23.34% | 1.85K |
—
|
—
| 9.76K |
Mar 1
| |||
Form 4
| +23.85% | 1.52K |
—
|
—
| 7.91K |
Mar 6
| |||
Form 4
| -11.84% | -858.00 |
$109.92 | -$94,311.36 | 6.39K |
Nov 17
| |||
Form 4
| +68.80% | 2.95K |
—
|
—
| 7.25K |
Mar 7
| |||
Form 4
|
∞
| 4.29K |
—
|
—
| 4.29K |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $2.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| -28.31% | -10.00K |
$4.29 | -$42,855.00 | 25.33K |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
∞
| 35.33K |
—
|
—
| 35.33K |
Jul 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||